AstraZeneca AZN -1.94% has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business. The upfront cash ...

CAMBRIDGE, England--(BUSINESS WIRE)--Today AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through ...

AstraZeneca ’s AZN 3.11% longest-serving chief executive, Pascal Soriot, has no plans to step down for now as the company tries to grab a slice of the booming weight-loss market and aims to ...

AstraZeneca on Tuesday said it would invest $50billion (£37.1billion) in the US by 2030, creating 'tens of thousands' of highly skilled 'direct and indirect' jobs, while 'powering growth and ...

AstraZeneca has admitted in court documents that its COVID-19 vaccine could cause a rare but deadly blood-clotting condition, potentially exposing the UK pharmaceutical giant to tens of millions ...

AstraZeneca has agreed to acquire U.S.-based vaccine developer Icosavax for $1.1 billion, the companies announced Tuesday, to gain access to experimental vaccines targeting common respiratory ...

Tangent AstraZeneca reported $33.7 billion in total revenue through the third quarter and raised its guidance for total revenue this year from a low-to-mid single-digit percentage increase to a ...